Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1996 | 12-1995 | 09-1995 | 06-1995 | 03-1995 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 130 | -9,350 | N/A | N/A | N/A |
| Depreciation Amortization | 1,620 | 9,130 | N/A | N/A | N/A |
| Other Operating Activity | -1,520 | 4,740 | 0 | 0 | 0 |
| Operating Cash Flow | $230 | $4,520 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | -6,500 | 7,100 | 0 | 0 | 0 |
| Investing Cash Flow | $-6,500 | $7,100 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 440 | -560 | 0 | 0 | 0 |
| Financing Cash Flow | $440 | $-560 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 25,410 | 14,350 | N/A | N/A | N/A |
| End Cash Position | 19,580 | 25,410 | N/A | N/A | N/A |
| Net Cash Flow | $-5,820 | $11,050 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 230 | 4,520 | N/A | N/A | N/A |
| Free Cash Flow | 230 | 4,520 | 0 | 0 | 0 |